Although initially considered an age-related phenomenon, a recent study by Hagiwara et al.367 found significantly higher (15% vs 8.5%) mutations in CH-related genes versus community controls in 2860 long-term survivors of pediatric cancer with a mean follow-up time of 23.5 years. This evidence concerns the gene C4B and cancer.